Can you provide a comprehensive IV study guide for a pharmacist, including common IV admixture preparations, drug‑diluent compatibility (e.g., amphotericin B in two 50 mL D5W bags), labeling requirements, infusion rates, and precautions for incompatibilities?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

IV Pharmacy Study Guide for Common Preparations

Amphotericin B Preparations

Amphotericin B deoxycholate (conventional AmB) must be reconstituted with Sterile Water for Injection (no bacteriostatic agents) and diluted in 5% Dextrose (D5W) with pH >4.2 1. This is critical—never use saline solutions as they cause precipitation 1.

Reconstitution Protocol:

  • Add 10 mL Sterile Water for Injection directly to 50 mg vial to create 5 mg/mL concentrate
  • Use minimum 20-gauge needle
  • Shake immediately until clear
  • Further dilute 1:50 with D5W (pH >4.2) to achieve final concentration of 0.1 mg/mL 1

Volume Considerations:

For 25 mg amphotericin B deoxycholate, use 250 mL D5W minimum—NOT 500 mL 2. Research demonstrates that 25 mg/500 mL preparations exceed particulate matter limits (>10 μm particles), cause filter blockage during infusion, and result in only 11.3% of drug actually infusing 2. The 25 mg/250 mL or 50 mg/500 mL preparations meet pharmacopeial standards and infuse completely 2.

pH Buffer Requirements:

If D5W pH is <4.2, add 1-2 mL of buffer containing 1:

  • Dibasic sodium phosphate (anhydrous) 1.59 g
  • Monobasic sodium phosphate (anhydrous) 0.96 g
  • Water for Injection 100 mL
  • Sterilize buffer before adding

Administration Parameters:

  • Infuse over 2-6 hours at ≤50 mg/hour 3
  • Dose: 0.7-1.0 mg/kg/day (up to 1.5 mg/kg/day for severe infections) 4, 1
  • Use in-line filter with mean pore diameter ≥1.0 micron 1
  • Premedicate with diphenhydramine or acetaminophen to prevent infusion reactions 4
  • Give 1 L normal saline before and after infusion to reduce nephrotoxicity 4

Stability:

  • 0.25 mg/mL in D5W: 35 days refrigerated (4-8°C)
  • 1.4 mg/mL in D5W: 36 hours refrigerated 3
  • No bacteriostatic agent present—strict aseptic technique required 1
  • Light protection unnecessary 3

Liposomal Amphotericin B (L-AmB)

Liposomal formulations are NOT interchangeable with conventional amphotericin B deoxycholate 4, 5.

Dosing:

  • Standard: 3-5 mg/kg/day IV 4, 6
  • CNS involvement (mucormycosis): 10 mg/kg/day 4
  • Infuse over minimum 1-2 hours 5

Key Difference:

Liposomal AmB has reduced nephrotoxicity compared to deoxycholate formulation but similar infusion-related reactions 5. ABLC (amphotericin B lipid complex) is NOT bioequivalent—rough conversion is 3 mg/kg L-AmB ≈ 5 mg/kg ABLC 5.

Vancomycin Preparations

Fortified Ophthalmic Solutions:

For bacterial keratitis, prepare three concentration options 7:

15 mg/mL: Add 33 mL of 0.9% sodium chloride (no preservatives) or artificial tears to 500 mg vial

25 mg/mL: Add 20 mL of 0.9% sodium chloride (no preservatives) or artificial tears to 500 mg vial

50 mg/mL: Add 10 mL of 0.9% sodium chloride (no preservatives) or artificial tears to 500 mg vial

Refrigerate and shake well before instillation 7.

Systemic IV Dosing:

  • Adults: 15-20 mg/kg/dose IV every 8-12 hours 8, 9
  • Pediatric: 15 mg/kg/dose IV every 6 hours 8, 9
  • Target trough: 15-20 µg/mL for severe infections 8
  • Infuse slowly to prevent "red man syndrome"

Cefazolin/Ceftazidime Fortified Solutions

50 mg/mL concentration for both 7:

  1. Add 9.2 mL artificial tears to 1 g powder vial
  2. Dissolve completely
  3. Take 5 mL of this solution and add to 5 mL artificial tears
  4. Refrigerate and shake before use

Aminoglycosides (Tobramycin/Gentamicin)

Fortified Ophthalmic (14 mg/mL):

  • Withdraw 2 mL from injectable vial (40 mg/mL)
  • Add to 5 mL bottle of ophthalmic solution
  • Refrigerate and shake before use 7

Systemic Dosing:

  • Once-daily dosing preferred: 5-7 mg/kg IV daily 10
  • Traditional: Gentamicin 1 mg/kg IV every 8 hours 11, 9
  • Monitor renal function and drug levels

Critical Compatibility Principles

Never Mix:

  • Amphotericin B with saline solutions (causes precipitation) 1
  • Amphotericin B with bacteriostatic agents like benzyl alcohol 1
  • Drugs in D5W with pH <4.2 without buffering for amphotericin B 1

Container Selection:

  • Amphotericin B: Use polyolefin, glass, or PVC containers; avoid evacuated containers with buffers 3
  • Non-PVC bags show higher particle counts than polypropylene bags for some medications 12

Infusion Rate Monitoring:

Critical for vancomycin, amphotericin B, acyclovir, ganciclovir, and foscarnet 10. Rapid infusion increases adverse events.

Storage and Stability

Refrigeration Required (4-8°C):

  • Amphotericin B admixtures (no preservative) 3
  • Fortified antibiotic ophthalmic solutions 7
  • Vancomycin fortified solutions 7

Room Temperature Acceptable:

  • TMP-SMX (do not refrigerate) 10

Protect from Light:

  • Specific agents only (check individual monographs) 10

Common Pitfalls to Avoid

  1. Using 500 mL D5W for 25 mg amphotericin B deoxycholate—this causes filter clogging and inadequate drug delivery 2

  2. Forgetting pH check of D5W before amphotericin B dilution—pH must be >4.2 or precipitation occurs 1

  3. Assuming liposomal and conventional amphotericin B are interchangeable—they have different dosing and are NOT equivalent 4, 5

  4. Using saline with amphotericin B—always use D5W only 1

  5. Omitting premedication for amphotericin B—prevents severe infusion reactions 4

  6. Rapid vancomycin infusion—causes red man syndrome; infuse slowly 10

References

Research

Influence of 5% dextrose volume on amphotericin B deoxycholate preparation.

The Journal of pharmacy and pharmacology, 2016

Research

Practical guidelines for preparing and administering amphotericin B.

American journal of hospital pharmacy, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.